Key result
Adults with congenital heart disease overestimate normal life expectancy by ~22 percentage points vs. cardiologists.
Why the study?
Although survival in congenital heart disease has improved, life expectancy remains subnormal, prompting an investigation into how adult patients, partners, and cardiologists estimate life expectancy and patient preferences for end-of-life communication.
How do middle-aged adults with congenital heart disease and their partners estimate the patients' life expectancy compared with treating cardiologists, and what are their experiences and preferences regarding end-of-life communication 40-53 years after childhood surgery?
Cohort (n=201)
No
How do middle-aged adults with congenital heart disease and their partners estimate the patients' life expectancy compared with treating cardiologists, and what are their experiences and preferences regarding end-of-life communication 40-53 years after childhood surgery?
Middle-aged adults with congenital heart disease—particularly those with moderate/severe lesions—Hold significantly more optimistic views of their life expectancy than their treating cardiologists, and nearly half wish to discuss end-of-life care despite 85.1% having never done so.
Patients' optimistic views and rare end-of-life discussions signal communication gaps; leaves open whether targeted interventions align perceptions in adult congenital heart disease.
Aims Although survival of patients with congenital heart disease (CHD) improved significantly over time, life expectancy is still not normal. We aimed to investigate how adult patients, their partners, and treating cardiologists estimated the individual life expectancy of CHD patients. Furthermore, preferences regarding end-of-life (EOL) communication were investigated. Methods and results In this study, we included 202 patients (age: 50 ± 5) who were operated in childhood (<15 years old) between 1968 and 1980 for one of the following diagnoses: atrial septal defect, ventricular septal defect, pulmonary stenosis, tetralogy of Fallot, or transposition of the great arteries. A specific questionnaire was administered to both the patients and their partners, exploring their perceived life expectancy and EOL wishes. Two cardiologists independently assessed the life expectancy of each patient. Most adults with CHD believed their life expectancy to be normal. However, significant differences were found between estimated life expectancy by the cardiologist and patients (female: P = 0.001, male: P = 0.002) with moderate/severe defects, as well as for males with mild defects (P = 0.011). Regarding EOL communication, 85.1% of the patients reported that they never discussed EOL with a healthcare professional. Compared with patients with mild CHD, significantly more patients with moderate/severe defect discussed EOL with a physician (P = 0.011). The wish to discuss EOL with the cardiologist was reported by 49.3% of the patients and 41.7% of their partners. Conclusion Adult patients, especially with moderate/severe CHD, perceived their life expectancy as normal, whereas cardiologists had a more pessimistic view than their patients. Increased attention is warranted for discussions on life expectancy and EOL to improve patient-tailored care.
No takes yet. Share an insight, caveat, or question.
Pelosi et al. (2023) conducted a cohort in Adult congenital heart disease (CHD) 40-53 years after childhood surgery (n=201). Patient self-perception of congenital heart disease life expectancy and end-of-life communication vs. Cardiologist and partner assessment of life expectancy; mild vs. moderate/severe CHD was evaluated on Normal perceived life expectancy (same as healthy peers) (p=<0.001). Adults with congenital heart disease perceived their life expectancy as normal more often than cardiologists (67.2% vs 45.3%, P<0.001), while 85.1% had never discussed end-of-life care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: